Aims: To study the effect of Beta–adrenergic agonist (salbutamol) and Beta adrenergic antagonist (atenolol)
on salivary protein concentration and to study relation between salivary protein concentration
and oral health. Materials and Methods: This study was carried out on 45 individuals; 15 individuals
of them were apparently healthy with no history of systemic diseases and represent a control group, the
second group which comprised 15 subjects were given adrenergic agonist drug (salbutamol) for treatment
of asthma, and third group (15 individuals) were given adrenegic antagonist drug (atenolol) for
treatment of hypertension. subjects were selected from the out patients attending Oral Surgery Department,
College of Dentistry, University of Mosul. The samples of saliva were collected using spitting
method and oral hygiene index simplified was recorded for each individual and total protein concentration
of these saliva samples were determined. Its relation to oral health was measured according
to simplified oral hygiene index by Greene and Vermillion. Results: The results of this study revealed
that in all study groups, significant differences were present for both salivary protein concentration and
oral health scores and there is correlation between salivary protein concentration and oral health in patients
receiving atenolol. Conclusions: Chronic treatment with adrenergic agonist and antagonist drugs,
resulted in changes in salivary protein concentration and those will affect the oral health of patients
treated by these drugs.
Table of Contents
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Research Objectives and Focus Areas
This study aims to evaluate the impact of Beta-adrenergic agonist (salbutamol) and Beta-adrenergic antagonist (atenolol) treatments on salivary protein concentrations and to determine how these medication-induced variations influence the oral health status of patients.
- Effects of salbutamol on salivary protein levels in asthmatic patients.
- Effects of atenolol on salivary protein levels in hypertensive patients.
- Correlation between salivary protein concentration and oral health indices.
- Clinical implications of medication-induced oral health changes.
- Evaluation of oral hygiene using the Simplified Oral Hygiene Index.
Excerpt from the Book
DISCUSSION
Many types of receptors exist in salivary glands t, suggesting that salivary glands may contain target systems for many drugs like Beta receptors drugs. Salbutamol is one of the Beta 2 agonist drugs that are widely used for treatment of bronchial asthma, it acts on Beta 2 receptors selectively and produces bronchodilation, this drug will lead to production of less saliva but of high protein concentration. On the other hand, it will decrease the amount of water reabsorption into the duct of salivary gland, therefore proteins can hardly pass the duct lining because they depend on the transepithelial water transport of these ducts; the net result of thist is reduction in the mount of salivary protein concentration in the secreted saliva (17–19).
On the other hand, atenolol which is one of the Beta 2 adrenoceptor antagonist, that are widely used for treatment of hypertension, can cause alteration in salivary protein concentration, it stimulate salivary glands to produce copious saliva of low protein concentration, so the protein output in saliva will be reduced, according to that the reduction in salivary protein concentration caused by atenolol will be more than that caused by salbutamol (20).
Summary of Chapters
1. Introduction: Outlines the protective role of saliva and establishes the hypothesis that systemic medications like beta-agonists and beta-antagonists may alter salivary composition and subsequent oral health.
2. Materials and Methods: Details the study design involving 45 participants divided into control, asthmatic (salbutamol), and hypertensive (atenolol) groups, describing collection protocols and biochemical analysis via the Biuret method.
3. Results: Presents statistical data showing significant differences in salivary protein concentration and oral health scores between the study groups, highlighting specific correlations in patients treated with atenolol.
4. Discussion: Interprets the findings by explaining how beta-adrenergic drugs interact with salivary gland receptors to alter protein output and confirms that medication-induced salivary changes correlate with oral health status.
5. Conclusions: Summarizes that chronic treatment with these drugs negatively affects salivary protein levels, creating a clinical challenge in maintaining oral health for patients requiring these medications.
Keywords
Salivary proteins, adrenergic agonist, adrenergic antagonist, salbutamol, atenolol, oral health, Simplified Oral Hygiene Index, salivary gland function, bronchodilator, hypertension, systemic disease, protein concentration, oral disease, dental care, biuret method.
Frequently Asked Questions
What is the primary focus of this research?
The study investigates how long-term medication use, specifically Beta-adrenergic agonists and antagonists, affects the concentration of proteins in saliva and the overall oral health of patients.
Which specific drugs were evaluated in the study?
The study evaluated the effects of salbutamol, used for treating asthma, and atenolol, used for treating hypertension.
What was the main research goal?
The objective was to determine if there is a quantitative variation in salivary protein concentration induced by these drugs and if this variation correlates with the patients' oral health status.
How was the data collected and analyzed?
Saliva samples were collected from 45 individuals using a standardized spitting method, and proteins were analyzed using the Biuret method. Oral hygiene was assessed using the Simplified Oral Hygiene Index.
What were the major findings of the research?
The results showed that both types of drugs significantly reduced salivary protein concentrations and that these changes negatively influenced the oral health scores of the patients compared to the control group.
Which scientific method was used to determine the significance of the results?
The researchers utilized the one-way ANOVA test to compare the groups and Duncan's Multiple Analysis Range Test to identify specific differences between the treatment groups and the control group.
How does atenolol specifically affect salivary output?
The study concludes that atenolol stimulates salivary glands to produce larger volumes of saliva with a low protein concentration, leading to an overall reduction in total protein output.
Why is this research important for dental professionals?
Understanding these medication-induced changes helps dentists identify why patients on certain therapies may be more susceptible to oral diseases, allowing for better preventative care and oral health management.
- Quote paper
- Dr. Amer A. Taqa (Author), Tahani A. Al-Sandook (Author), Fayhaa A. M. Al-Mashhadane (Author), 2007, Salivary Protein Components and Oral Health in Patients Undergoing Therapy with Beta Adrenegic Agonist and Antagonist, Munich, GRIN Verlag, https://www.grin.com/document/207702
